Learn about our
Structural Heart Portfolio
Explore the interactive heart model below to learn more about our products and solutions across the structural heart spectrum.
Mitral Regurgitation
A condition in which the mitral valve does not close completely during the contraction of the left ventricle, causing blood to leak backward into the left atrium.Click on a product name to learn more about our therapy solutions
MitraClip™ Therapy
A minimally invasive Transcatheter Edge-to-Edge Repair (TEER) therapy that delivers a treatment option for select patients with mitral regurgitation who would otherwise go untreated.Learn More
Epic™ Plus Mitral Stented Tissue Valve
Intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic mitral heart valve.Learn More
×
Aortic Stenosis
Aortic stenosis occurs when leaflets become thick or stiff, which causes a narrowing of the aortic valve. As a result, the valve doesn’t open and close properly, which reduces or obstructs blood flow from the left ventricle to the aorta.Click on a product name to learn more about our therapy solutions
Navitor™ TAVI System
A minimally invasive heart valve implant for individuals with symptomatic severe aortic stenosis who are a high or greater risk for traditional open-heart surgery.**TAVI is also referred to as TAVR (Transcatheter Aortic Valve Replacement)Learn More
Epic™ Max Aortic Stented Tissue Valve
An optimal solution for surgical aortic valve replacement of a diseased, damaged, or malfunctioning native or previously implanted aortic valve.Learn More
Regent™ Mechanical Heart Valve
Intended for patients requiring replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic valve.Learn More
×
Stroke Risk Reduction
Left atrial appendage (LAA) closure reduces the risk of stroke in non-valvular AF patient. Percutaneous closure of the patent foramen ovale (PFO) to prevent thrombus formation.Click on a product name to learn more about our therapy solutions
Amplatzer™ Amulet™ LAA Occluder
A percutaneous transcatheter device intended to reduce the risk of thrombus embolization from the left atrial appendage (LAA) in suitable patients with nonvalvular atrial fibrillation.Learn More
Amplatzer™ Talisman™ PFO Occluder
Designed for patent foramen ovale (PFO) closure, the Amplatzer™ Talisman™ PFO occluder reduces the risk of recurrent ischemic stroke.Learn More
×
Congenital defects
Congenital heart defects can involve the walls of the heart, the heart valves, and arteries and veins near the heart, disrupting normal blood flow.Click on a product name to learn more about our therapy solutions
Amplatzer™ Septal Occluder
A percutaneous transcatheter device for patients requiring atrial septal defect (ASD) closure.Learn More
Amplatzer™ VSD Occluder
Ventricular septal defects (VSDs) are the most common congenital heart defect, and Amplatzer™ Muscular VSD Occluders provide minimally invasive treatment options.Learn More
×
Tricuspid Regurgitation
A condition in which the leaflets (or flaps) of the tricuspid valve do not close properly, causing blood to flow backwards into the right atrium.Click on a product name to learn more about our therapy solutions
TriClip™ Therapy
A minimally invasive, non-surgical treatment option for severe, symptomatic tricuspid regurgitation patients who are at a high risk for surgery, despite optimal medical therapy.Learn More
×
© 2024 Abbott. All rights reserved. MAT-2115844 v4.0 | Item approved for U.S. use only.
Test
Lorem Ipsum dolor sit amen.
Test
Lorem Ipsum dolor sit amen.
Test
Lorem Ipsum dolor sit amen.
Test
Lorem Ipsum dolor sit amen.
Test
Lorem Ipsum dolor sit amen.
Test
Lorem Ipsum dolor sit amen.